Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Artenstein

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
The Journal of Infectious Diseases|June 1, 1978
Safety and immunogenicity of a Neisseria meningitidis type 2 protein vaccine in animals and humansW D Zollinger, R E Mandrell, P Altieri, et al.
The Journal of Experimental Medicine|July 1, 1979
Antibody-dependent cell-mediated antibacterial activity of human mononuclear cells. I. K lymphocytes and monocytes are effective against meningococi in cooperation with human imune seraG H Lowell, L F Smith, M S Artenstein, et al.
Bulletin of the World Health Organization|January 1, 1971
Meningococcal infections. 3. Studies of group A polysaccharide vaccinesM S Artenstein, W C Branche, J G Zimmerly, et al.
American Journal of Diseases of Children (1960)|March 1, 1975
Coxsackievirus B5 infection and aseptic meningitis in neonates and childrenR Marier, W Rodriguez, R J Chloupek, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
The Journal of Infectious Diseases|June 1, 1978
Safety and immunogenicity of a Neisseria meningitidis type 2 protein vaccine in animals and humansW D Zollinger, R E Mandrell, P Altieri, et al.
The Journal of Experimental Medicine|July 1, 1979
Antibody-dependent cell-mediated antibacterial activity of human mononuclear cells. I. K lymphocytes and monocytes are effective against meningococi in cooperation with human imune seraG H Lowell, L F Smith, M S Artenstein, et al.
Bulletin of the World Health Organization|January 1, 1971
Meningococcal infections. 3. Studies of group A polysaccharide vaccinesM S Artenstein, W C Branche, J G Zimmerly, et al.
American Journal of Diseases of Children (1960)|March 1, 1975
Coxsackievirus B5 infection and aseptic meningitis in neonates and childrenR Marier, W Rodriguez, R J Chloupek, et al.
Pageof 3